NORWALK HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.9M
- Transactions
- 392
- Companies
- 28
- Average per transaction
- $9,982
Who reported the payments
| Pfizer | $1,834,561 |
| Amgen | $1,464,142 |
| Novartis | $182,359 |
| EMD Serono, Inc. | $112,036 |
| Seagen Inc. | $53,101 |
| Morphosys AG | $48,693 |
| Janssen Research & Development, LLC | $45,723 |
| Siemens Medical Solutions USA, Inc. | $30,713 |
| GE HealthCare | $28,306 |
| Bristol Myers Squibb | $19,277 |
| Stryker | $15,079 |
| Incyte Corporation | $13,452 |
| Genentech, Inc. | $13,357 |
| Pharmacyclics LLC, An Abbvie Company | $13,012 |
| Alkermes, Inc. | $8,040 |
| Gilead | $6,971 |
| Ares Trading SA | $6,203 |
| Viseon, Inc. | $5,515 |
| Applied Medical Technology Inc | $5,138 |
| KARL Storz Endoscopy-america | $3,870 |
| Bio-rad Laboratories, Inc. | $1,511 |
| Arrow International, Inc. | $740 |
| Bioventus LLC | $423 |
| AstraZeneca | $380 |
| Welch Allyn | $250 |
| Boston Scientific | $132 |
| BD | $100 |
| Olympus America Inc. | $25 |